Information:
Fel:
ID
12940
Beskrivning
Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT00003694
Länk
https://clinicaltrials.gov/show/NCT00003694
Nyckelord
Versioner (1)
- 2016-01-07 2016-01-07 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
7 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694
Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
chronic myelogenous leukemia
Item
histologic diagnosis of chronic myelogenous leukemia (cml) in chronic phase; patients in either accelerated or blastic phases are not eligible; clonal cytogenetic evolution alone does not exclude patients
boolean
C0023473 (UMLS CUI [1])
inclusion criteria
Item
patients must meet one or more of the following criteria:
boolean
C1512693 (UMLS CUI [1])
philadelphia chromosome
Item
cytogenetically determined philadelphia chromosome (ph+)
boolean
C0031526 (UMLS CUI [1])
bcr/abl protein
Item
bcr/abl protein detectable by immunoblotting
boolean
C0004891 (UMLS CUI [1])
fusion transcripts for bcr/abl
Item
polymerase chain reaction (pcr) positive fusion transcripts for bcr/abl
boolean
C0004891 (UMLS CUI [1])
C0032520 (UMLS CUI [2])
C0032520 (UMLS CUI [2])
bcr/abl translocation present by fluorescence in situ hybridization (fish)
Item
bcr/abl translocation present by fluorescence in situ hybridization (fish)
boolean
C0004891 (UMLS CUI [1])
C0162789 (UMLS CUI [2])
C0162789 (UMLS CUI [2])
registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+
Item
registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+
boolean
C0031526 (UMLS CUI [1])
C0004891 (UMLS CUI [2])
C0004891 (UMLS CUI [2])
hydroxyurea
Item
no more than eight weeks of prior hydroxyurea therapy
boolean
C0020402 (UMLS CUI [1])
homoharringtonine
Item
no previous therapy with homoharringtonine (hht)
boolean
no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible
Item
no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible
boolean
C0733470 (UMLS CUI [1])
C0006463 (UMLS CUI [2])
C0010711 (UMLS CUI [3])
C0006463 (UMLS CUI [2])
C0010711 (UMLS CUI [3])
allogeneic bone marrow transplant
Item
must not be a candidate for an early allogeneic bone marrow transplant; potential transplant candidates must be counseled about alternative donor transplants and must decline that treatment option
boolean
C0005961 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control
Item
non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
bilirubin
Item
bilirubin =< x upper limit of normal
boolean
C1278039 (UMLS CUI [1])
creatinine
Item
creatinine =< 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])